1. Home
  2. AIBZ vs TTRX Comparison

AIBZ vs TTRX Comparison

Compare AIBZ & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bitzero Holdings Inc. Common Shares

AIBZ

Bitzero Holdings Inc. Common Shares

N/A

Current Price

$4.17

Market Cap

358.4M

Sector

N/A

ML Signal

N/A

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$13.06

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIBZ
TTRX
Founded
N/A
2015
Country
Canada
United States
Employees
8
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.4M
298.8M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
AIBZ
TTRX
Price
$4.17
$13.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
363.2K
69.8K
Earning Date
N/A
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.44
$2.57
52 Week High
$9.91
$14.39

Technical Indicators

Market Signals
Indicator
AIBZ
TTRX
Relative Strength Index (RSI) 32.57 72.88
Support Level N/A $9.02
Resistance Level $7.21 N/A
Average True Range (ATR) 0.39 1.04
MACD -0.09 0.37
Stochastic Oscillator 8.87 83.21

Price Performance

Historical Comparison
AIBZ
TTRX

About AIBZ Bitzero Holdings Inc. Common Shares

Bitzero Holdings Inc is a provider of IT energy infrastructure and high-efficiency power for data centers. It focuses on data center development, Bitcoin mining, and obtaining strategic data center hosting partnerships. The company has four data center locations in the North American and Scandinavian regions, powered by clean, low-carbon energy sources. The company is driven by experience in infrastructure and a passion for positive change to become the international leader in Blockchain mining and HPC hosting in a sustainable fashion that emphasizes the long-term value proposition for all stakeholders.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: